Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell, Cutaneous

Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.

20 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Cutaneous trial results

Completed

IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

NCT03902184

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles (UCLA) - Medical Center Los Angeles, California, United States
  • Irvine Medical Center Orange, California, United States
  • Stanford University Stanford, California, United States
View all 53 locations
View Trial Details
Completed

A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin

NCT04998331

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • Hospital General Vega Baja San Bartolomé, Alicante, Spain
  • Hospital Universitario de Alava Vitoria-Gasteiz, Araba, Spain
  • Ico Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Galdakao Galdakao, Bizkaia, Spain
View all 30 locations
View Trial Details
Completed

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)

NCT02953301

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Medizinische Universität Graz Graz, Austria
  • Medizinische Universität Wien Vienna, Austria
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitaire Ziekenhuizen Leuven, Belgium
View all 54 locations
View Trial Details

Related conditions